 |
 |
|
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
What Is the Natural Course of Idiopathic Pulmonary Fibrosis?
21 June 2005 | Volume 142 Issue 12 Part 1 | Page I-23
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis." It is in the 21 June 2005 issue of Annals of Internal Medicine (volume 142, pages 963-967). The authors are F.J. Martinez, S. Safrin, D. Weycker, K.M. Starko, W.Z. Bradford, T.E. King Jr., K.R. Flaherty, D.A. Schwartz, P.W. Noble, G. Raghu, and K.K. Brown, for the IPF Study Group.
What is the problem and what is known about it so far?
Idiopathic pulmonary fibrosis (IPF) is an uncommon disease in which the lungs become scarred and stiff for no apparent reason. Patients note shortness of breath and cough, and many eventually die of lung failure. Treatment may include medications to decrease inflammation or further scarring or lung transplantation. How IPF naturally worsens over time is uncertain because the disease is uncommon and many patients receive a diagnosis in more advanced stages of disease. The researchers of this study previously performed a study in which patients with mild to moderate IPF were randomly assigned to take an experimental treatment or a placebo. The study focused on whether patients improved with treatment. However, the researchers realized that observing the patients who took placebo could provide valuable information about what happens over time to patients with untreated IPF.
Why did the researchers do this particular study?
To see how IPF naturally worsens over time in a large number of patients with mild to moderate disease.
Who was studied?
168 patients randomly assigned to receive placebo in a study of treatment for IPF. Most were white men.
How was the study done?
The researchers collected information on patients' lung function and symptoms every 12 weeks from the time the patients enrolled in the study until the study's conclusion (about 1.5 years). They also collected information on the number of hospitalizations and deaths.
What did the researchers find?
Patients' lung function did not generally worsen over the observation period. About one third of patients were hospitalized, many more than once; many hospitalizations were for presumed infection. About 1 in 5 patients died, almost half within weeks of the first worsening of symptoms.
What are the limitations of the study?
The researchers could not provide detailed information about the reasons patients were hospitalized and why they died. The study included only patients who had not previously improved with steroids. The findings may not apply to patients who did not previously take steroids or to those who took steroids and improved.
What are the implications of the study?
IPF does not always slowly worsen over time. Instead, many patients with IPF remain stable for long periods, then suddenly get worse and die. This pattern suggests that patients with IPF who do not improve with steroids should be monitored closely and might possibly undergo lung transplantation while their symptoms are still relatively mild.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  R. B. Hubbard, C. Smith, I. Le Jeune, J. Gribbin, and A. W. Fogarty The Association between Idiopathic Pulmonary Fibrosis and Vascular Disease: A Population-based Study Am. J. Respir. Crit. Care Med., December 15, 2008; 178(12): 1257 - 1261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. King Jr and R. M. du Bois Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis Eur. Respir. Rev., December 1, 2008; 17(109): 105 - 107. [Full Text] [PDF]
|
|
|
|
|
|
G. Raghu, A. G. Nicholson, and D. Lynch The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias Eur. Respir. Rev., December 1, 2008; 17(109): 108 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Brown and A. U. Wells Recent clinical trials in idiopathic pulmonary fibrosis and the BUILD-1 study Eur. Respir. Rev., December 1, 2008; 17(109): 116 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Miyazaki, T. Tateishi, T. Akashi, Y. Ohtani, N. Inase, and Y. Yoshizawa Clinical Predictors and Histologic Appearance of Acute Exacerbations in Chronic Hypersensitivity Pneumonitis Chest, December 1, 2008; 134(6): 1265 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Raghu, K. K. Brown, U. Costabel, V. Cottin, R. M. du Bois, J. A. Lasky, M. Thomeer, J. P. Utz, R. K. Khandker, L. McDermott, et al. Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 948 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Olson, T. J. Huie, S. D. Groshong, G. P. Cosgrove, W. J. Janssen, M. I. Schwarz, K. K. Brown, and S. K. Frankel Acute Exacerbations of Fibrotic Hypersensitivity Pneumonitis: A Case Series Chest, October 1, 2008; 134(4): 844 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui Interstitial lung disease guideline Thorax, September 1, 2008; 63(Suppl_5): v1 - v58. [Full Text] [PDF]
|
|
|
|
|
|
M. Akira, T. Kozuka, S. Yamamoto, and M. Sakatani Computed Tomography Findings in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 372 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Daniels, E. S. Yi, and J. H. Ryu Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Eur. Respir. J., July 1, 2008; 32(1): 170 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Collard and F. J. Martinez Basis of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Japanese Patients Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1398 - 1398. [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Thomsen Mediastinoscopy and Video-Assisted Thoracoscopic Surgery: Anesthetic Pitfalls and Complications Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2008; 12(2): 128 - 132. [Abstract] [PDF]
|
|
|
|
|
|
T. R. McMillan, B. B. Moore, J. B. Weinberg, K. M. Vannella, W. B. Fields, P. J. Christensen, L. F. van Dyk, and G. B. Toews Exacerbation of Established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 771 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W A Wuyts, M Thomeer, L J Dupont, and G M Verleden An algorithm for referral of patients with IPF for lung transplantation Thorax, March 1, 2008; 63(3): 292 - 292. [Full Text] [PDF]
|
|
|
|
|
|
K. R. Flaherty High-Resolution Computed Tomography and the Many Faces of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 367 - 368. [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. Moore and C. M. Hogaboam Murine models of pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L152 - L160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 190 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Tzelepis, S. P. Toya, and H. M. Moutsopoulos Occult connective tissue diseases mimicking idiopathic interstitial pneumonias Eur. Respir. J., January 1, 2008; 31(1): 11 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Raymond, M. Schaller, C. M. Hogaboam, N. W. Lukacs, R. Rochford, and S. L. Kunkel Toll-like Receptors, Notch Ligands, and Cytokines Drive the Chronicity of Lung Inflammation Proceedings of the ATS, December 1, 2007; 4(8): 635 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Konigshoff, A. Wilhelm, A. Jahn, D. Sedding, O. V. Amarie, B. Eul, W. Seeger, L. Fink, A. Gunther, O. Eickelberg, et al. The Angiotensin II Receptor 2 Is Expressed and Mediates Angiotensin II Signaling in Lung Fibrosis Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 640 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hyzy, S. Huang, J. Myers, K. Flaherty, and F. Martinez Acute Exacerbation of Idiopathic Pulmonary Fibrosis Chest, November 1, 2007; 132(5): 1652 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Collard, B. B. Moore, K. R. Flaherty, K. K. Brown, R. J. Kaner, T. E. King Jr., J. A. Lasky, J. E. Loyd, I. Noth, M. A. Olman, et al. Acute Exacerbations of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 636 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. O. Rosas, P. Ren, N. A. Avila, C. K. Chow, T. J. Franks, W. D. Travis, J. P. McCoy Jr., R. M. May, H.-P. Wu, D. M. Nguyen, et al. Early Interstitial Lung Disease in Familial Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 698 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. T. Bates, G. S. Davis, A. Majumdar, K. J. Butnor, and B. Suki Linking Parenchymal Disease Progression to Changes in Lung Mechanical Function by Percolation Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 617 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Brown Roger S. Mitchell Lecture. Rheumatoid Lung Disease Proceedings of the ATS, August 15, 2007; 4(5): 443 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Noth and F. J. Martinez Recent Advances in Idiopathic Pulmonary Fibrosis Chest, August 1, 2007; 132(2): 637 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Parambil, J. L. Myers, M.-C. Aubry, and J. H. Ryu Causes and Prognosis of Diffuse Alveolar Damage Diagnosed on Surgical Lung Biopsy Chest, July 1, 2007; 132(1): 50 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Nathan, P. W. Noble, and R. M. Tuder Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Connecting the Dots Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 875 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Sweet, M. G. Patti, L. E. Leard, J. A. Golden, S. R. Hays, C. Hoopes, and P. R. Theodore Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1078 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gunther, B. Enke, P. Markart, P. Hammerl, H. Morr, J. Behr, G. Stahler, W. Seeger, F. Grimminger, I. Leconte, et al. Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study Eur. Respir. J., April 1, 2007; 29(4): 713 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. U. Wells and C. M. Hogaboam Update in Diffuse Parenchymal Lung Disease 2006 Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 655 - 660. [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Kreider, J. Hansen-Flaschen, N. N. Ahmad, M. D. Rossman, L. R. Kaiser, J. C. Kucharczuk, and J. B. Shrager Complications of Video-Assisted Thoracoscopic Lung Biopsy in Patients with Interstitial Lung Disease Ann. Thorac. Surg., March 1, 2007; 83(3): 1140 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Nathan, O. A. Shlobin, S. Ahmad, S. Urbanek, and S. D. Barnett Pulmonary Hypertension and Pulmonary Function Testing in Idiopathic Pulmonary Fibrosis Chest, March 1, 2007; 131(3): 657 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hamada, S. Nagai, S. Tanaka, T. Handa, M. Shigematsu, T. Nagao, M. Mishima, M. Kitaichi, and T. Izumi Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis Chest, March 1, 2007; 131(3): 650 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. O. Rosas and N. Kaminski When It Comes to Genes--IPF or NSIP, Familial or Sporadic--They're All the Same Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 5 - 6. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Studer and N. Kaminski Towards Systems Biology of Human Pulmonary Fibrosis Proceedings of the ATS, January 1, 2007; 4(1): 85 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Tiitto, R Bloigu, U Heiskanen, P Paakko, V L Kinnula, and R Kaarteenaho-Wiik Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia Thorax, December 1, 2006; 61(12): 1091 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Cottin Interstitial lung disease: are we missing formes frustes of connective tissue disease? Eur. Respir. J., November 1, 2006; 28(5): 893 - 896. [Full Text] [PDF]
|
|
|
|
 |
|
 O.J. Dempsey, K.M. Kerr, L. Gomersall, H. Remmen, and G.P. Currie Idiopathic pulmonary fibrosis: an update QJM, October 1, 2006; 99(10): 643 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Raghu, D. Weycker, J. Edelsberg, W. Z. Bradford, and G. Oster Incidence and Prevalence of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 810 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Flaherty, A.-C. Andrei, S. Murray, C. Fraley, T. V. Colby, W. D. Travis, V. Lama, E. A. Kazerooni, B. H. Gross, G. B. Toews, et al. Idiopathic Pulmonary Fibrosis: Prognostic Value of Changes in Physiology and Six-Minute-Walk Test Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Raghu Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches. Eur. Respir. J., September 1, 2006; 28(3): 463 - 465. [Full Text] [PDF]
|
|
|
|
|
|
K. M. Antoniou, A. G. Nicholson, M. Dimadi, K. Malagari, P. Latsi, A. Rapti, N. Tzanakis, R. Trigidou, V. Polychronopoulos, and D. Bouros Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis Eur. Respir. J., September 1, 2006; 28(3): 496 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Crowley, P. Kelly, and J. J. Egan Acute Exacerbations in Idiopathic Pulmonary Fibrosis Ann Intern Med, February 7, 2006; 144(3): 218 - 218. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Kim, H. R. Collard, and T. E. King Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proceedings of the ATS, January 1, 2006; 3(4): 285 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Martinez and K. Flaherty Pulmonary function testing in idiopathic interstitial pneumonias. Proceedings of the ATS, January 1, 2006; 3(4): 315 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Walter, H. R. Collard, and T. E. King Jr. Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proceedings of the ATS, January 1, 2006; 3(4): 330 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Acute Deterioration in Idiopathic Pulmonary Fibrosis Journal Watch (General), July 26, 2005; 2005(726): 3 - 3. [Full Text]
|
|
Read all Rapid Responses
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
